Eleni Domzaridou
BSc, MSc, PhD
Data Scientist
Eleni is a data scientist in the UK Biobank Health outcomes team within the Nuffield Department of Population Health. Currently, she contributes to a programme aimed at enhancing health outcomes phenotyping in UK Biobank. She also conducts multidisciplinary research at the intersection of statistics and clinical investigation. Her primary expertise lies in utilising large electronic health records, such as the Clinical Practice Research Datalink, secondary care data from Hospital Episode Statistics, mortality data, as well as deprivation and national costing data. She has worked on projects investigating adverse outcomes in patients prescribed opioids, antibiotics, or corticosteroids in primary care.
Eleni earned her PhD in Epidemiology and MSc in Health Data Science from the University of Manchester, and her BSc in Pharmacy from Aristotle University in Greece. During her doctoral training, which was funded by the NIHR GM-PSTRC, she gained experience in propensity scoring methods, statistical modelling, and techniques for controlling confounding variables in observational research. She applied a range of statistical methods, including inverse probability of treatment weighting, Poisson, negative binomial, and Cox regression modelling. Before joining the University of Oxford, she was a postdoctoral researcher at the University of Manchester.
Recent publications
-
Healthcare utilisation and associated costs for methadone versus buprenorphine recipients: Examination of interlinked primary and secondary care electronic health records in England.
Journal article
Domzaridou E. et al, (2024), Drug Alcohol Rev, 43, 1845 - 1855
-
Incidence, antimicrobial prescribing practice and associated healthcare costs of paediatric otorrhoea in primary care in the UK: A longitudinal population study.
Journal article
Heward E. et al, (2024), Br J Gen Pract
-
Prescribing and Research in Medicines Management - PRIMM 34th Annual Scientific Meeting, Manchester, UK, 17 May 2024, Drug Utilisation: Learning from Practice & Research to Improve Patient Outcomes.
Conference paper
(2024), Pharmacoepidemiol Drug Saf, 33 Suppl 1
-
Recognizing the complexities of co-prescriptions and life-style factors in opioid agonist treatment: A response from Eleni Domzaridou, Matthew J. Carr, Tim Millar, Roger T. Webb and Darren M. Ashcroft.
Journal article
Domzaridou E. et al, (2024), Addiction, 119, 967 - 968
-
Non-fatal overdose risk associated with prescribing opioid agonists concurrently with other medication: Cohort study conducted using linked primary care, secondary care and mortality records.
Journal article
Domzaridou E. et al, (2023), Addiction, 118, 2374 - 2383